{"id":516,"date":"2021-08-23T10:25:16","date_gmt":"2021-08-23T09:25:16","guid":{"rendered":"https:\/\/ceventrix.com\/?page_id=516"},"modified":"2021-11-08T11:10:44","modified_gmt":"2021-11-08T10:10:44","slug":"pasienten-hvem-kan-ha-nytte-av-ceventrix","status":"publish","type":"page","link":"https:\/\/ceventrix.com\/en\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/","title":{"rendered":"Pasienten &#8211; hvem kan ha nytte av CEVENTRIX\u2122?"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"516\" class=\"elementor elementor-516\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-153379cd elementor-section-height-min-height elementor-section-boxed elementor-section-height-default elementor-section-items-middle\" data-id=\"153379cd\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;shape_divider_bottom&quot;:&quot;curve&quot;}\">\n\t\t\t\t\t<div class=\"elementor-shape elementor-shape-bottom\" aria-hidden=\"true\" data-negative=\"false\">\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 1000 100\" preserveaspectratio=\"none\">\n    <path class=\"elementor-shape-fill\" d=\"M1000,4.3V0H0v4.3C0.9,23.1,126.7,99.2,500,100S1000,22.7,1000,4.3z\"\/>\n<\/svg>\t\t<\/div>\n\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-182b9dd7\" data-id=\"182b9dd7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-587c9a5d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"587c9a5d\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-3004851c\" data-id=\"3004851c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-24594dba elementor-widget elementor-widget-heading\" data-id=\"24594dba\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">The patient - Who may benefit from CEVENTRIX\u2122?  \u200b<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-490f37fd elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"490f37fd\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-33ce41c9\" data-id=\"33ce41c9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4192e5d elementor-widget elementor-widget-text-editor\" data-id=\"4192e5d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">A study with propionate (Duscha et al, 2020) has been performed with both RRMS, SPMS, and PPMS showing benefits of propionate with all subtypes.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In the study by Duscha et al, reduced levels of propionate in stool and serum compared to healthy control subjects was found in all subtypes of MS (RRMS, SPMS, and PPMS), including also the de novo cohort. Supplementation with propionate restored stool and serum levels of propionate in all subgroups by two weeks.  Subsequently, the number and function of Treg cells was restored, and TH17 was reduced towards normal levels in all subgroups.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The changes in Treg numbers and function appeared to be independent of variations in background medications, as did the observed clinical benefits. These results though should be interpreted with care as numbers are often too small for meaningful statistical analyses. Please see Duscha et al 2020 for more information.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">No serious adverse events were reported with 3 years of use and less than 5% of subjects had mild adverse events. The reported events were abdominal distension, flatulence, and nausea.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">CEVENTRIX\u2122 can be used for dietary management of all subgroups of MS, irrespective of background medication.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-16b3b5c8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"16b3b5c8\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1f77f65e\" data-id=\"1f77f65e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Pasienten &#8211; hvem kan ha nytte av CEVENTRIX\u2122? En studie med propionat (Duscha et al, 2020) har blitt utf\u00f8rt med b\u00e5de RRMS, SPMS og PPMS som viser fordeler med propionat med alle undertyper. I studien av Duscha et al. ble det funnet reduserte propionatniv\u00e5er i avf\u00f8ring og serum sammenlignet med friske kontrollpersoner i alle undertyper [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"parent":501,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-516","page","type-page","status-publish","hentry","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pasienten - hvem kan ha nytte av CEVENTRIX\u2122? - Ceventrix<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ceventrix.com\/en\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pasienten - hvem kan ha nytte av CEVENTRIX\u2122? - Ceventrix\" \/>\n<meta property=\"og:description\" content=\"Pasienten &#8211; hvem kan ha nytte av CEVENTRIX\u2122? En studie med propionat (Duscha et al, 2020) har blitt utf\u00f8rt med b\u00e5de RRMS, SPMS og PPMS som viser fordeler med propionat med alle undertyper. I studien av Duscha et al. ble det funnet reduserte propionatniv\u00e5er i avf\u00f8ring og serum sammenlignet med friske kontrollpersoner i alle undertyper [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ceventrix.com\/en\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/\" \/>\n<meta property=\"og:site_name\" content=\"Ceventrix\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-08T10:10:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/\",\"url\":\"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/\",\"name\":\"Pasienten - hvem kan ha nytte av CEVENTRIX\u2122? - Ceventrix\",\"isPartOf\":{\"@id\":\"https:\/\/ceventrix.com\/#website\"},\"datePublished\":\"2021-08-23T09:25:16+00:00\",\"dateModified\":\"2021-11-08T10:10:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ceventrix.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"For helsepersonell\",\"item\":\"https:\/\/ceventrix.com\/for-helsepersonell\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pasienten &#8211; hvem kan ha nytte av CEVENTRIX\u2122?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ceventrix.com\/#website\",\"url\":\"https:\/\/ceventrix.com\/\",\"name\":\"Ceventrix\",\"description\":\"For kosholdsbehandling av MS\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ceventrix.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pasienten - hvem kan ha nytte av CEVENTRIX\u2122? - Ceventrix","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ceventrix.com\/en\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/","og_locale":"en_GB","og_type":"article","og_title":"Pasienten - hvem kan ha nytte av CEVENTRIX\u2122? - Ceventrix","og_description":"Pasienten &#8211; hvem kan ha nytte av CEVENTRIX\u2122? En studie med propionat (Duscha et al, 2020) har blitt utf\u00f8rt med b\u00e5de RRMS, SPMS og PPMS som viser fordeler med propionat med alle undertyper. I studien av Duscha et al. ble det funnet reduserte propionatniv\u00e5er i avf\u00f8ring og serum sammenlignet med friske kontrollpersoner i alle undertyper [&hellip;]","og_url":"https:\/\/ceventrix.com\/en\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/","og_site_name":"Ceventrix","article_modified_time":"2021-11-08T10:10:44+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/","url":"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/","name":"Pasienten - hvem kan ha nytte av CEVENTRIX\u2122? - Ceventrix","isPartOf":{"@id":"https:\/\/ceventrix.com\/#website"},"datePublished":"2021-08-23T09:25:16+00:00","dateModified":"2021-11-08T10:10:44+00:00","breadcrumb":{"@id":"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ceventrix.com\/for-helsepersonell\/pasienten-hvem-kan-ha-nytte-av-ceventrix\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ceventrix.com\/"},{"@type":"ListItem","position":2,"name":"For helsepersonell","item":"https:\/\/ceventrix.com\/for-helsepersonell\/"},{"@type":"ListItem","position":3,"name":"Pasienten &#8211; hvem kan ha nytte av CEVENTRIX\u2122?"}]},{"@type":"WebSite","@id":"https:\/\/ceventrix.com\/#website","url":"https:\/\/ceventrix.com\/","name":"Ceventrix","description":"For kosholdsbehandling av MS","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ceventrix.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/pages\/516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/comments?post=516"}],"version-history":[{"count":5,"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/pages\/516\/revisions"}],"predecessor-version":[{"id":3498,"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/pages\/516\/revisions\/3498"}],"up":[{"embeddable":true,"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/pages\/501"}],"wp:attachment":[{"href":"https:\/\/ceventrix.com\/en\/wp-json\/wp\/v2\/media?parent=516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}